Disclosure requirement - Medicult ASA

Orkla ASA owns 3.110.100 shares in Medicult ASA. This represents 10.95% of outstanding shares in the company. Orkla ASA has been assigned voting rights based on proxies for 1.625.000 shares in Medicult ASA. The proxies apply exclusively to the extraordinary general meeting in Medicult ASA on 10 June 2009. This entails that Orkla ASA have the right to vote for a total of 4.735.100 shares in Medicult ASA on the extraordinary general meeting on 10 June 2009. This represents 16.68% of outstanding shares in the company.
 
 
Orkla ASA,
Oslo, 27 May 2009
 
Contact:
Siv Merethe S. Brekke, VP Orkla Investor Relations, Tel: +47 2254 4455